Lv32
220 积分 2021-08-18 加入
Impurity qualification requirements for drug-linkers related impurities used to generate antibody-drug conjugates
19小时前
已完结
A Science-Based Proposal for the Identification Threshold of Organic Impurities in Drug–Linker Intermediates Used to Produce Antibody–Drug Conjugates
22小时前
已完结
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
13天前
已完结
Process Scale Purification of Antibodies
13天前
已完结
Regulatory and Quality Considerations of Antibody-drug Conjugates
1个月前
已完结
Study on the hole and knob related impurities in the purification of bispecific antibodies
1个月前
已完结
Principles and Practices of Lyophilization in Product Development and Manufacturing
4个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
4个月前
已完结
Lyophilized Drug Product Cake Appearance: What Is Acceptable?
7个月前
已完结
Elucidation of cell culture impacts on hydroxylysine levels in monoclonal antibodies using high‐throughput analytical quantification and media components
8个月前
已完结
皖公网安备34019202002308
